Clinical Indication

For adjunctive use with an oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT).


Not yet reviewed.

Date of classification

September 2023


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.